WO2020031214A2 - Drug releasing pad - Google Patents
Drug releasing pad Download PDFInfo
- Publication number
- WO2020031214A2 WO2020031214A2 PCT/IR2019/050022 IR2019050022W WO2020031214A2 WO 2020031214 A2 WO2020031214 A2 WO 2020031214A2 IR 2019050022 W IR2019050022 W IR 2019050022W WO 2020031214 A2 WO2020031214 A2 WO 2020031214A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- pad
- wall
- people
- description
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Definitions
- Claimed invention in the field of medicine, especially in the field of inhaling medicine is used.
- Asal Foroughiipour has invented the invention of a respiratory mask equipped with inhalation medication which can’t be useful to some people and has a great deal of contact with the environment.
- This product works like a small non-disturbing pad inserted into the nostril wall and begins the treatment process by releasing the drug.
- the glue on the surface of the adhesive also absorbs the air due to the moisture content and increases the efficiency of the drug.
- a three-layer pad with top-down layers comprising damp lint and contact surface enhancer (1), drug storage part (2) and adhesive layer (3) to attach to the inner nasal wall. All parts must be of a material that does not cause sensitivity to the most people. It is recommended to use sterile cotton for this purpose.
- Connecting the dampening layer of the contact surface (1) to the drug storage area (2) must be such that the drug can be absorbed into the villi (1), thereby facilitating drug release into the environment. Attach the drug storage layer (2) to the adhesive layer (3) in such a way that the two layers do not interfere with each other (a very thin insulation layer between them).
- the drug is injected into the middle part of the pad (this is done by the manufacturer, not the consumer); the drug evaporates in the immediate vicinity of the internal temperature and creates a long-lasting effect. Attach the pad to the inner wall of the nose (3) (on the right side of the inner wall of the right nasal cavity and on the left side of the inner wall of the left side of the nasal cavity) And the drug starts to work.
- the adhesive used should not be allergic.
- This method is useful in almost any situation because it is not affected by environmental conditions and is hidden from view.
- a wide range of medications can be used.
- the drug is sterile and remains sterile until use (unlike ointment that is permanently in contact with hands).
- Section A In this section, the overall shape of the pad is shown, which is based on the shape of the nasal duct designed to fit easily into the inner wall of the nose.
- the size offered is the most optimal size according to the reviews. It should be noted that the sizes are intended for adult humans and require size reduction to produce samples for children.
- Section B This section shows the thickness, the order and the type of pad layers.
- the top-down layer is the contact surface enhancer layer with lint extensions (1), drug storage layer (2) and finally the adhesive layer (3) to attach to the inner nasal wall.
- the thickness of all sections can be changed depending on the amount of medication and the type of problem.
- Pad Material For the production of different layers of the pad materials should not be allergic to most people and are not harmful to the environment because of their naturalness.
- the desired material is sterile cotton. These fibers are widely used in various parts and in various forms due to their absorption of moisture, ease of coating and availability.
- the invention is used in the pharmaceutical industry, as a platform for the use of respiratory drugs.
Abstract
Respiratory problems are one of the most common problems people have around the world. There are various ways to solve this problem, including the use of drops, types of ointments, etc. Each of which has its own problems. The design eliminates all the problems of the old stuff like unpleasantness, temporary effect, and has a stronger and longer lasting effect, plus it's very easy to use. This product works like a small non-disturbing pad inserted into the nostril wall and begins the treatment process by releasing the drug. The glue on the surface of the adhesive also absorbs the air due to the moisture content and increases the efficiency of the drug.
Description
Claimed invention in the field of medicine, especially in the field of inhaling medicine is used.
Patent No. 139550140003010032 on 11/11/2016Ms. Asal Foroughiipour has invented the invention of a respiratory mask equipped with inhalation medication which can’t be useful to some people and has a great deal of contact with the environment.
This product works like a small non-disturbing pad inserted into the nostril wall and begins the treatment process by releasing the drug. The glue on the surface of the adhesive also absorbs the air due to the moisture content and increases the efficiency of the drug.
With the advent of the world and the rise of air pollution, new types of diseases have emerged, mainly due to changes in the breathing air, which are related to the respiratory system.
The methods available so far for solving respiratory problems such as ointments, nasal drops and spray types have their problems. For example, the ointment has an unpleasant sensation and is not usable in all situations and provides short-term effect.
Therefore, the need for a new, simpler, and long-lasting approach is evident.
A three-layer pad with top-down layers comprising damp lint and contact surface enhancer (1), drug storage part (2) and adhesive layer (3) to attach to the inner nasal wall. All parts must be of a material that does not cause sensitivity to the most people. It is recommended to use sterile cotton for this purpose.
Connecting the dampening layer of the contact surface (1) to the drug storage area (2) must be such that the drug can be absorbed into the villi (1), thereby facilitating drug release into the environment. Attach the drug storage layer (2) to the adhesive layer (3) in such a way that the two layers do not interfere with each other (a very thin insulation layer between them).
The drug is injected into the middle part of the pad (this is done by the manufacturer, not the consumer); the drug evaporates in the immediate vicinity of the internal temperature and creates a long-lasting effect. Attach the pad to the inner wall of the nose (3) (on the right side of the inner wall of the right nasal cavity and on the left side of the inner wall of the left side of the nasal cavity) And the drug starts to work.
The adhesive used should not be allergic.
For a better and longer lasting effect, it is best to clean the nose before use.
This method is useful in almost any situation because it is not affected by environmental conditions and is hidden from view.
The advantages of this method over previous methods are that, like ointment, it does not create an unpleasant sensation and does not disrupt the intra-nasal villi that have the function of removing the suspended particles, but rather helps the drug to seep through the nasal surface and absorbs suspended particles. It can be completely removed from the nose by changing the pad and also has a long-lasting effect against the spray and drops (depending on the type and amount of drug used).
Due to the fact that the pad is hidden during the day, it is usable and does not disturb the person during sleep.
It can be used by a wide range of people because of the use of substances that are not Allergic to most people.
It can be used by almost all ages because of the ability to control the amount of drug used and resize.
A wide range of medications can be used.
The drug is sterile and remains sterile until use (unlike ointment that is permanently in contact with hands).
Pad Material: For the production of different layers of the pad materials should not be allergic to most people and are not harmful to the environment because of their naturalness. The desired material is sterile cotton. These fibers are widely used in various parts and in various forms due to their absorption of moisture, ease of coating and availability.
The invention is used in the pharmaceutical industry, as a platform for the use of respiratory drugs.
Claims (13)
- The size of the actual design of the can varies.
- The materials of all parts must be the one that is mentioned in description.
- Plan offered (drawing) is just a concept and design ideas for a better understanding it can have varies design for more comfortable use.
- Adhesive materials should not be sensitive to most people.
- The pad itself should be made with non-sensitive material to most people as mentioned in the description.
- The amount of drug use in pad can be controlled.
- The volume of the drug in pad can be variant due to pad size change.
- The drug should be injected in the number 2 area marked in the drawing and described in the description.
- The drug should be certified by the expert and inject by the manufacturer to the pad.
- Meaning of drug is the substance that is injected into the pad in order to solve the problem (treatment) or create a sense of.
- Pad should be on the inner wall of the nose (on the left wall of the left channel and right wall at the right channel).
- It is permissible to use it at different ages due to the controlled use of the drug.
- Packaging should prevent contamination and loss of medication .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IR139750140003004142 | 2018-08-05 | ||
IR13973004140 | 2018-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020031214A2 true WO2020031214A2 (en) | 2020-02-13 |
Family
ID=69415703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IR2019/050022 WO2020031214A2 (en) | 2018-08-05 | 2019-08-05 | Drug releasing pad |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2020031214A2 (en) |
-
2019
- 2019-08-05 WO PCT/IR2019/050022 patent/WO2020031214A2/en active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190254924A1 (en) | Therapeutic substance and acupressure system | |
JP4795370B2 (en) | Method for manufacturing nasal dilator | |
KR102028698B1 (en) | Mask having a Detachable Personal Nose Band | |
US3513839A (en) | Valved nose filter | |
US20120046607A1 (en) | Plug to be introduced into a passage such as a nasal passage or ear canal | |
US20100147307A1 (en) | Nasal cavity filter | |
ATE545442T1 (en) | MEDICAL DEVICE FOR INHALING AEROSOLIZED MEDICINAL PRODUCT WITH HELIOX | |
ITBS20130118A1 (en) | EQUIPMENT FOR ADJUSTABLE POSITIVE PRESSURE AEROSOLTERAPY | |
EE200300514A (en) | Phthalazinones, their use in the manufacture of medicaments for the treatment of respiratory symptoms and medicinal products containing them | |
KR101956637B1 (en) | Hygienic mask manufacturing method | |
WO2020031214A2 (en) | Drug releasing pad | |
CN103932428B (en) | The light mouth mask of the anti-haze of bionical wet type | |
CN204684393U (en) | A kind of children atomizing mask | |
CN104338169B (en) | A kind of Chinese medicine filter and preparation method thereof | |
DE102005039502A1 (en) | Mouthpiece for medicament inhaler, comprises peripheral double wall structure, forming inner nozzle for medicament-containing core jet and outer nozzle for sheath jet of air to improve drug delivery to lungs | |
CN205492700U (en) | Respirator structure | |
CN205672374U (en) | A kind of adelomorphic nose cup | |
CN203897346U (en) | Nose mask capable of filtering harmful PM2.5 (particulate matter 2.5) | |
CN205492694U (en) | Take gauze mask of damp proof structure | |
US20220233464A1 (en) | Cannabidiol infused foam element or surface | |
CN206837204U (en) | A kind of atomizing face mask fixing band | |
TWM594964U (en) | Additive mask | |
CN208892939U (en) | A kind of comfort bandage | |
KR20160133640A (en) | nose adhesion band for for nose treatment and nose take care | |
CN202569235U (en) | Novel nose plug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19847448 Country of ref document: EP Kind code of ref document: A2 |